243.00
+1.81(+0.75%)
Currency In CNY
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
11000
First IPO Date
December 15, 2021
| Name | Title | Pay | Year Born |
| Mr. John V. Oyler | Co-Founder, Executive Chairman & Chief Executive Officer | 20.45M | 1968 |
| Mr. Chan Lee | General Counsel & Senior Vice President | 7.76M | 1969 |
| Mr. Wang Lai Ph.D. | Global Head of R&D | 8.67M | 1978 |
| Dr. Xiaobin Wu Ph.D. | President, Chief Operating Officer & GM of China | 13.25M | 1963 |
| Mr. Aaron Rosenberg | Chief Financial Officer | 13.9M | 1977 |
| Dr. Xiaodong Wang Ph.D. | Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder | 30.64M | 1963 |
| Mr. Marcello Damiani | Chief Technology Officer | 0 | 1970 |
| Ms. Liza Heapes | Head of Investor Relations | 0 | N/A |
| Mr. Yang Ji | Chief Compliance Officer | 0 | N/A |
| Mr. Titus B. Ball | Vice President & Chief Accounting Officer | 0 | 1973 |
BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.